Pitch Introduction
The Inner Gize Shark Tank India pitch introduced a high-tech solution to one of the most pressing modern problems: chronic stress. Founded by medical and engineering experts, Inner Gize presented a wearable device designed to stimulate the vagus nerve, helping users transition from a ‘fight or flight’ state to a ‘rest and recover’ state. The founders entered the tank seeking ₹54 Lakhs for 1.5% equity, valuing their company at a significant ₹36 Crores. Their presentation wasn’t just about a product; it was about a deeply personal journey of resilience, featuring a founder who survived stage 2 cancer and a rare autoimmune disease.
Business Overview
Inner Gize is a neurotech company based in Delhi that specializes in mental wellness through wearable technology. The company addresses the ‘stress crisis’ in India, where nearly 70% of the urban population reports symptoms of stress and sleep deprivation. Unlike traditional supplements or meditation apps that often see high drop-off rates, Inner Gize offers a tangible, clinically validated hardware solution that provides immediate physiological relief.
The business model focuses on a razor-and-blade strategy. While the main device is sold as a one-time purchase, it requires specialized adhesive patches that must be replaced, creating a recurring revenue stream. Initially, the company plans to target the B2B segment, including wellness centers, luxury gyms, and corporate offices, before scaling into a full-scale Direct-to-Consumer (D2C) brand. This approach allows them to validate the technology in professional settings while managing customer acquisition costs.
Product Details
The core product is a small, discreet wearable device that fits comfortably behind the ear. It utilizes a patented technology known as the Neuro-Acoustic Vagal Model. By delivering gentle, low-frequency electrical stimulation to the auricular branch of the vagus nerve, the device triggers the parasympathetic nervous system. This biological ‘hack’ forces the body to calm down, lowering cortisol levels and improving heart rate variability (HRV). The device is controlled via a mobile application that allows users to start 10-minute sessions at their convenience. Each starter pack includes the device, a charging case, and 12 conductive patches.
Market Position
Inner Gize positions itself as a premium, solution-oriented wearable. In a market flooded with smartwatches that merely track data, Inner Gize actively intervenes to improve health. Its primary competitive advantage lies in its non-invasive nature and clinical backing. While global competitors like GammaCore exist in the US, they are often bulky, expensive, and require a doctor’s prescription. Inner Gize has miniaturized this technology into a consumer-friendly form factor that is significantly more affordable, priced at ₹5,000 compared to international alternatives that can cost upwards of ₹2 Lakhs annually.
| Business Detail | Information |
|---|---|
| Company Name | Inner Gize |
| Founders | Dr. Siddhant Bhargava, Shalmali Kadu, Mitansh Khurana |
| Product Type | Neurotech Wearable |
| Price Range | ₹5,000 (Starter Pack) |
| Primary Channel | B2B & D2C (Hybrid) |
| Headquarters | Delhi, Delhi |
About Founder’s
The founding team of Inner Gize brings a mix of medical expertise and high-level engineering. Dr. Siddhant Bhargava, a well-known celebrity nutritionist and co-founder of Food Darzee, led the pitch with a powerful story of survival. Diagnosed with Lupus at age 20 and later with Stage 2 Thyroid Cancer at 26, Dr. Siddhant turned his personal health battles into a mission to solve stress-related illnesses. His resilience and medical background gave the pitch immediate credibility.
- Dr. Siddhant Bhargava: MBBS graduate from Nair Hospital Mumbai with an AIR 214; celebrity nutritionist for stars like Alia Bhatt.
- Shalmali Kadu: Instrumentation and Control Engineer from Pune; diagnosed with Type 1 Diabetes, which fueled her interest in non-invasive health tech.
- Mitansh Khurana: Gold medalist in Mathematics and Computing from NSUT Delhi; the technical brain behind the miniaturization of the device.
- Common Goal: The founders met at various startup conferences and decided to collaborate when they realized their shared interest in neurotech solutions for stress.
Shark’s and Founder’s QnA
How does this technology actually work on the body?
There are two types of nervous systems: sympathetic (fight and flight) and parasympathetic (rest and recovery). In today’s age, constant stimulation keeps us in sympathetic mode. We stimulate your vagus nerve with gentle electrical impulses, which calms the system down. It essentially reminds your body how to reach equilibrium again.
Is the device safe for long-term use?
Yes, it is 100% safe. More than 5,000 peer-reviewed studies have been published on vagus nerve stimulation technology globally. We have also conducted our own preclinical studies on 110 people and are compliant with the IC 60601 protocol for medical devices.
What is the difference between this and global competitors like GammaCore?
GammaCore is a bulky device that requires you to apply a hydrogel to your neck and costs about $600 per month on a prescription basis. We have miniaturized it into a discreet wearable that you can wear behind your ear anywhere, at a much lower price point, without needing a prescription for general wellness.
What is your current funding status?
We have already raised ₹2 Crores, which includes ₹1.1 Crores in equity and ₹90 Lakhs in grants. We are currently closing a ₹4 Crore round at a ₹36 Crore post-money valuation, led by Antler with participation from high-profile angels. Alia Bhatt is also interested in investing in this round.
What are the margins on the device?
The production cost is approximately ₹1,200, and we sell it for ₹5,000. This gives us healthy gross margins even before we consider the recurring revenue from the patch refills, which sell for ₹500 for a pack of eight.
Why start with B2B instead of going straight to the consumer?
Because this is a new technology, we don’t want to burn massive amounts of cash on marketing to uneducated consumers immediately. By selling to wellness centers and gyms first, we get expert validation and ‘word-of-mouth’ credibility, which will make the later D2C expansion much more efficient.
Key Stats & Financials
At the time of the pitch, Inner Gize was in its pre-launch phase but had already secured significant institutional interest. The founders revealed a clear path to profitability based on high manufacturing margins and a recurring revenue model for consumables.
Revenue and Profitability
- Total Capital Raised: ₹2 Crores (including grants).
- Gross Margin: Over 75% on the hardware device (₹1,200 cost vs ₹5,000 retail).
- Requested Valuation: ₹36 Crores.
- Investment Request: ₹54 Lakhs for 1.5% equity.
- Recurring Revenue: ₹500 per patch set, ensuring high customer lifetime value (LTV).
Financial Breakdown
| Metric | Amount / Value |
|---|---|
| Pre-Seed Funding Raised | ₹1.1 Crores |
| Grants Won (BIRAC/BIG) | ₹90 Lakhs | ₹4 Crores |
| Hardware Unit Cost | ₹1,200 |
| MRP per Unit | ₹5,000 |
| Patch Refill Cost | ₹500 |
Business Potential and TAM
The mental health tech sector is one of the fastest-growing industries globally. According to industry reports, more than 53% of urban Indians experience high-stress levels regularly. The global wearable technology market was valued at over $60 Billion in 2023 and is projected to grow significantly as consumers shift from passive tracking to active health management. Inner Gize operates at the intersection of bioelectronics and consumer wellness, a space that is currently underserved in India.
Market Size Analysis
The Total Addressable Market (TAM) for stress management in India includes nearly 150 million urban professionals who are likely to spend on health and wellness. With the growing awareness of bio-hacking and neuro-stimulation, the potential for non-invasive medical wearables is massive. If Inner Gize captures even 1% of the high-income urban demographic, they could reach annual revenues exceeding ₹75 Crores.
Growth Opportunities
- Subscription Model: Moving beyond simple patch sales to a digital health subscription within the app.
- Clinical Expansion: Seeking FDA/CDSCO approval to target clinical conditions like chronic migraines.
- Corporate Wellness: Partnering with large IT firms to provide devices as part of employee mental health benefits.
- Global Export: Leveraging the low manufacturing cost in India to export the device to Western markets.
Inner Gize: Ideal Target Audience & Demographics
| Demographic | Details |
|---|---|
| Primary Age Group | 25–45 Years |
| Secondary Age Group | 45–60 Years |
| Interests | Bio-hacking, Yoga, Mental Health, Productivity |
| Platform Preference | LinkedIn, Instagram, Wellness Forums |
| Geography | Tier 1 Cities (Delhi, Mumbai, Bengaluru) |
| Buying Behavior | Early Adopters, High Disposable Income |
Marketing and Distribution Strategy
Inner Gize’s strategy is designed to build authority before achieving scale. By using a medical professional like Dr. Siddhant as the face of the brand, they establish immediate trust in a category where consumers are often skeptical.
Customer Acquisition
The company intends to keep Customer Acquisition Costs (CAC) low by utilizing B2B2C channels. By placing the device in ‘experience zones’ within premium gyms and wellness retreats, they allow potential customers to test the product before buying. This reduces the friction associated with buying a high-tech health gadget online without a physical demo.
Distribution Channels
- Wellness Centers: Exclusive partnerships for in-session treatments.
- E-commerce: Selling via their own website and premium health marketplaces.
- Clinics: Distribution through specialized rheumatologists and psychiatrists.
- Corporate Tie-ups: Bulk licensing for employee well-being programs.
Social Media and Content Strategy
The brand focuses on educational content that explains the science of the vagus nerve. By using influencer marketing (specifically from the health and bio-hacking niche), they aim to create a ‘cool factor’ around the device. Their app also serves as a content platform, providing guided sessions that complement the electrical stimulation.
Inner Gize Shark Tank Deal Outcome
The pitch sparked intense interest among the Sharks due to the high barrier to entry and the founders’ credentials. Aman Gupta, Ritesh Agarwal, and Azhar Iqubal eventually teamed up to offer a consolidated deal.
| Shark | Offer Detail |
|---|---|
| Ritesh Agarwal | Offered ₹54 Lakhs for 1.5% equity (matched original ask). |
| Aman Gupta | Offered ₹54 Lakhs for 2.5% equity. |
| Azhar Iqubal | Offered ₹54 Lakhs for 1.5% equity. |
| Peyush Bansal | Exited (Found it too early for his specific thesis). |
| Final Decision | ₹1 Crore for 4.2% equity (Split between Aman, Ritesh, and Azhar). |
Inner Gize Post-Show Update
According to Inc42, following their appearance on Shark Tank India, Inner Gize successfully closed their pre-seed funding round, raising a total of ₹6.5 Crores. The brand has since seen a massive surge in interest from corporate wellness partners and is in the process of rolling out its B2B distribution network across major Indian metros.
Business Analysis & Lessons
Inner Gize represents a shift in the Indian startup ecosystem from pure software or e-commerce plays to Deep Tech and hardware innovation. The founders correctly identified that mental health is a massive problem, but also recognized that people are looking for effortless solutions. By moving the solution from ‘mindset’ (meditation) to ‘physiology’ (nerve stimulation), they lowered the barrier to user adoption.
The pitch was a masterclass in combining emotional storytelling with technical expertise. Dr. Siddhant’s personal medical history didn’t just generate sympathy; it provided proof of his personal commitment and skin-in-the-game. For other entrepreneurs, this highlights the importance of the ‘Why’ behind the business, especially in health-related industries where trust is the primary currency.
Key Takeaways
- Resilience as an Asset: Personal struggle can be a powerful engine for innovation and an incredible trust-builder for investors.
- Hardware/Software Hybrid: Pure hardware is hard to scale; combining it with an app and recurring consumables (patches) makes the business model much more robust.
- Strategic B2B Entry: Instead of fighting for attention in the noisy D2C market, starting with B2B wellness centers provides expert validation.
- Valuation Realism: Despite a high ₹36 Crore valuation, the founders had the metrics and existing term sheets (Antler) to defend their numbers.
Pitch Conclusion
Inner Gize managed to impress the Sharks not just with their technology, but with their clarity of vision and personal grit. By securing three major Sharks—Aman Gupta, Ritesh Agarwal, and Azhar Iqubal—they have gained more than just capital; they’ve gained mentors with expertise in distribution, hospitality, and digital scaling. As they move from pre-launch to a national presence, Inner Gize is a brand to watch in the evolving Indian wellness tech space. If you enjoyed this breakdown, check out Neuphony, MeduLance, and Matri.
[faq_accordian]